Field & Main Bank Abbott Laboratories Transaction History

Field & Main Bank

$278 Million
Q3 2024

A detailed history of Field & Main Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Field & Main Bank holds 11,835 shares of ABT stock, worth $1.35 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

11,835

Previous 12,901 8.26%

Holding current value

$1.35 Million

Previous $1.34 Million 0.67%

% of portfolio

0.49%

Previous 0.51%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$100.07 - $118.13 $106,674 - $125,926	-1,066 Reduced 8.26%	11,835 $1.35 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $10,778 - $12,031	107 Added 0.84%	12,901 $1.34 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $45,560 - $50,319	-416 Reduced 3.15%	12,794 $1.45 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $17,136 - $20,976	-190 Reduced 1.42%	13,210 $1.45 Million
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $71,169 - $85,391	-745 Reduced 5.27%	13,400 $1.3 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $28,218 - $31,441	-280 Reduced 1.94%	14,145 $1.54 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $42,715 - $50,278	-441 Reduced 2.97%	14,425 $1.46 Million
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $11,407 - $13,382	-120 Reduced 0.8%	14,866 $0
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $12,578 - $14,563	-130 Reduced 0.86%	14,986 $1.45 Million
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $33,070 - $39,971	-324 Reduced 2.1%	15,116 $1.64 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $37,056 - $45,188	-325 Reduced 2.06%	15,440 $1.83 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $7,509 - $9,194	65 Added 0.41%	15,765 $2.22 Million
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $27,998 - $30,974	-240 Reduced 1.51%	15,700 $1.86 Million
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $62,945 - $74,095	595 Added 3.88%	15,940 $1.85 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $16,326 - $19,234	150 Added 0.99%	15,345 $1.84 Million
Q4 2020 Feb 25, 2021	SELL	$105.0 - $114.42 $135,450 - $147,601	-1,290 Reduced 7.83%	15,195 $1.66 Million
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $103,553 - $125,757	1,130 Added 7.36%	16,485 $1.79 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $58,193 - $74,480	-760 Reduced 4.72%	15,355 $1.4 Million
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $19,627 - $21,850	-250 Reduced 1.53%	16,115 $1.4 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $31,099 - $33,721	-380 Reduced 2.27%	16,365 $1.37 Million
Q2 2019 Jul 22, 2019	SELL	$72.88 - $85.0 $5,466 - $6,375	-75 Reduced 0.45%	16,745 $1.41 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $2,317 - $2,802	-35 Reduced 0.21%	16,820 $1.35 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $21,588 - $23,827	375 Added 2.28%	16,855 $1.11 Million
Q1 2018 May 01, 2018	BUY	$56.27 - $63.62 $95,659 - $108,154	1,700 Added 11.5%	16,480 $0
Q4 2017 Jan 24, 2018	BUY	$53.68 - $57.47 $793,390 - $849,406	14,780	14,780 $844,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.

Account